The DOI matches its Crossref record; 150 of the 152 references it cites were found in a registry or an index; 41 of the 151 sources its claims cite were checked for support.
Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents
Abstract
Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurobehavioral disorders of childhood and can profoundly affect children’s academic achievement, well-being, and social interactions. The American Academy of Pediatrics first published clinical recommendations for evaluation and diagnosis of pediatric ADHD in 2000; recommendations for treatment followed in 2001. The guidelines were revised in 2011 and published with an accompanying process of care algorithm (PoCA) providing discrete and manageable steps by which clinicians could fulfill the clinical guideline’s recommendations. Since the release of the 2011 guideline, the Diagnostic and Statistical Manual of Mental Disorders has been revised to the fifth edition, and new ADHD-related research has been published. These publications do not support dramatic changes to the previous recommendations. Therefore, only incremental updates have been made in this guideline revision, including the addition of a key action statement related to diagnosis and treatment of comorbid conditions in children and adolescents with ADHD. The accompanying process of care algorithm has also been updated to assist in implementing the guideline recommendations. Throughout the process of revising the guideline and algorithm, numerous systemic barriers were identified that restrict and/or hamper pediatric clinicians’ ability to adopt their recommendations. Therefore, the subcommittee created a companion article (available in the Supplemental Information) on systemic barriers to the care of children and adolescents with ADHD, which identifies the major systemic-level barriers and presents recommendations to address those barriers; in this article, we support the recommendations of the clinical practice guideline and accompanying process of care algorithm.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
42 No full text of the sources · 19 Partly supported · 17 Own interpretation · 7 Own method · 5 Supported · 5 Sources not found · 4 Supported so far · 4 Not checked yet · 4 No basis given · 2 Couldn’t confirm · 1 Mixed support · accuracy not yet measured
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Boys are more likely to exhibit externalizing conditions like oppositional defiant disorder or conduct disorder.17,19,20”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > ADHD EPIDEMIOLOGY AND SCOPE
What the sources say
- Disputedcites [17] Elia, 2008, ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents, Child Adolesc Psychiatry Ment Health sourceExperimental — accuracy not yet measured
The Results report no significant sex differences in the diagnostic frequency patterns, including oppositional defiant disorder; the only exception was separation anxiety, which was more common in girls. The paper therefore does not support the claim that boys with ADHD are more likely than girls to have these externalizing conditions. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [19] Cuffe, ADHD and psychiatric comorbidity: functional outcomes in a school-based sample of children [published online ahead of print November 25, 2015], J Atten Disord sourceExperimental — accuracy not yet measured
The Results report that conduct disorder and oppositional defiant disorder were significantly more common among children with ADHD than among children without ADHD at both study sites. They do not report that boys with ADHD were more likely than girls with ADHD to have these conditions; the sex comparison was not supported by the passages found. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [20] Gaub, 1997, Gender differences in ADHD: a meta-analysis and critical review, J Am Acad Child Adolesc Psychiatry source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The majority of both boys and girls with ADHD also meet diagnostic criteria for another mental disorder.17,18”
- Also stated in: § KAS 3 · plain
“The majority of both boys and girls with ADHD also meet diagnostic criteria for another mental disorder.17,18”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > ADHD EPIDEMIOLOGY AND SCOPE
What the sources say
- Partly supportedcites [17] Elia, 2008, ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents, Child Adolesc Psychiatry Ment Health sourceExperimental — accuracy not yet measured
The Results report that 36.3% of the ADHD sample had no additional diagnosis, so a majority had at least one. The paper does not report this proportion separately for boys and girls; its statement that most diagnostic frequency patterns did not differ significantly by sex does not establish a majority in each group. The sample was also a selected clinical cohort. (LLM, conf=0.84)
- Not matchedcites [18] Centers for Disease Control and Prevention (CDC), 2005, Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003, MMWR Morb Mortal Wkly Rep
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § KAS 3 · plain
Every source the paper cites for this claim was checked and supports it.
In the paper
“Authors of longitudinal studies have found that ADHD treatments are frequently not maintained over time13 and impairments persist into adulthood.70”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Supportedcites [13] Molina, 2009, The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study, J Am Acad Child Adolesc Psychiatry source
The Discussion reports a dramatic decline in medication adherence as children with ADHD enter adolescence. In this longitudinal study, 62% of children taking medication at the 14-month assessment had stopped by the eight-year follow-up, supporting the claim that treatment is frequently not maintained over time. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“ADHD is a chronic condition; therefore, the PCC should manage children and adolescents with ADHD in the same manner that they would children and youth with special health care needs, following the principles of the chronic care model and the medical home (Table 5).”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Supportedcites [13] Molina, 2009, The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study, J Am Acad Child Adolesc Psychiatry source
The Discussion reports that, eight years after childhood diagnosis, the ADHD group still had substantially higher symptoms and poorer functioning than comparison children, and it recommends long-term monitoring. This supports describing ADHD as a chronic condition, although the paper notes that not every child continued to meet diagnostic criteria. (LLM, conf=0.88)
- Supportedcites [70] Sibley, 2017, Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity, J Child Psychol Psychiatry source
The Discussion (page unavailable) reports that ADHD symptoms persisted into young adulthood in approximately 60% of the childhood ADHD group under the authors’ optimized definition. This supports describing ADHD as a condition that can be chronic; the paper does not say it persists in everyone. The citing sentence’s care-management recommendation is not part of the claim attributed to this source. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“There is evidence that the diagnostic criteria for ADHD can be applied to preschool-aged children.33–39”
- Also stated in: § Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday) · hedged
“A review of the literature, including the multisite study of the efficacy of methylphenidate in preschool-aged children, found that the DSM-5 criteria could appropriately identify children with ADHD.25”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
What the sources say
- Not checked — no full text of the sourcecites [33] Lahey, 1998, Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children, J Am Acad Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [34] Pavuluri, 1999, Parent reported preschool attention deficit hyperactivity: measurement and validity, Eur Child Adolesc Psychiatry source
- Partly supportedcites [35] Harvey, 2009, Predicting attention-deficit/hyperactivity disorder and oppositional defiant disorder from preschool diagnostic assessments, J Consult Clin Psychol sourceExperimental — accuracy not yet measured
The Abstract reports that early assessments support the validity of ADHD diagnoses in preschool children, and the Discussion says children with ADHD could be distinguished from those with transient problems as early as age 3. The Methods specify that the study used DSM-IV symptom counts, not DSM-5 criteria, so the DSM-5 qualification in the supplied claim is not supported by this source. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [36] Keenan, 2000, More than the terrible twos: the nature and severity of behavior problems in clinic-referred preschool children, J Abnorm Child Psychol source
- Not checked — no full text of the sourcecites [37] Gadow, 2000, Comparison of attention-deficit/hyperactivity disorder symptom subtypes in Ukrainian schoolchildren, J Am Acad Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [38] Sprafkin, 2002, A DSM-IV-referenced screening instrument for preschool children: the Early Childhood Inventory-4, J Am Acad Child Adolesc Psychiatry source
- Partly supportedcites [39] Poblano, 2006, ECI-4 screening of attention deficit-hyperactivity disorder and co-morbidity in Mexican preschool children: preliminary results, Arq Neuropsiquiatr sourceExperimental — accuracy not yet measured
The Results report applying DSM-IV ADHD symptom criteria to preschool children, which supports the citing sentence’s general point. The paper does not address DSM-5, as specified in the supplied claim. The Discussion also says that the validity of very early ADHD diagnoses remains open to debate and that screening cannot itself provide a clinical diagnosis. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [25] Evans, 2018, Evidence-based psychosocial treatments for children and adolescents with attention deficit/hyperactivity disorder, J Clin Child Adolesc Psychol source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday) · hedged
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“They also have lower educational achievement than those without ADHD73,74 and increased rates of incarceration.75–77”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Not checked — no full text of the sourcecites [75] Barbaresi, 2013, Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study, Pediatrics source
- Could not verifycites [76] Chang, 2016, Association between prescription of major psychotropic medications and violent reoffending after prison release, JAMA sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) mentions ADHD among prisoners, and the Results examine violent reoffending in prisoners with ADHD. Neither compares incarceration rates for people with and without ADHD. Searches for ADHD, imprisonment, and incarceration risk found no passage making that comparison. (LLM, conf=0.76)
- Partly supportedcites [77] Lichtenstein, 2012, Medication for attention deficit-hyperactivity disorder and criminality, N Engl J Med sourceExperimental — accuracy not yet measured
The Results report substantially higher criminal-conviction rates among people with ADHD than among matched general-population controls (36.6% versus 8.9% for men; 15.4% versus 2.2% for women). But the Methods identify conviction as the main outcome; although the study linked to a prison register, these passages do not establish higher incarceration rates. (LLM, conf=0.86)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“As in the 2 previous guidelines, this recommendation is based on the evidence that for many individuals, ADHD causes symptoms and dysfunction over long periods of time, even into adulthood.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Partly supportedcites [13] Molina, 2009, The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study, J Am Acad Child Adolesc Psychiatry sourceExperimental — accuracy not yet measured
The Discussion reports that, eight years after childhood treatment, the MTA group still had substantially higher ADHD symptom scores and poorer functioning than former classmates in adolescence. It mentions evidence concerning early adulthood, but this study's follow-up does not establish that its participants' symptoms and dysfunction persisted into adulthood. (LLM, conf=0.86)
- Supportedcites [70] Sibley, 2017, Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity, J Child Psychol Psychiatry source
The Discussion reports that, among participants diagnosed with ADHD in childhood, approximately 60% met the study’s optimized symptom-persistence definition in young adulthood, and 41.1% met both that definition and an impairment criterion. This supports the claim that symptoms and dysfunction persist into adulthood for many individuals; the paper notes that persistence estimates depend on how they are defined. (LLM, conf=0.92)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Authors of longitudinal studies have found that ADHD treatments are frequently not maintained over time13 and impairments persist into adulthood.70”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Supportedcites [70] Sibley, 2017, Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity, J Child Psychol Psychiatry source
The Discussion reports that 41.1% of participants with childhood ADHD met both symptom-persistence criteria and the impairment criterion in young adulthood. The Introduction places the follow-up at a mean age of 24.7 years. These findings support the claim that impairments can persist into adulthood. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Learning and language problems are common comorbid conditions with ADHD.15”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > ADHD EPIDEMIOLOGY AND SCOPE
What the sources say
- Partly supportedcites [15] Mueller, 2012, Examining the comorbidity of language disorders and ADHD, Top Lang Disord sourceExperimental — accuracy not yet measured
The 'LI in Children with ADHD' summary (page not provided) reports high rates of co-occurring language impairment in children with ADHD, supporting the language-problems portion. The passages do not establish that learning problems, as distinct from language problems, are a common comorbid condition. (LLM, conf=0.86)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Recent research has established that girls with ADHD are more likely than boys to have a comorbid internalizing condition like anxiety or depression.21”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > ADHD EPIDEMIOLOGY AND SCOPE
What the sources say
- Partly supportedcites [21] Tung, 2016, Patterns of comorbidity among girls with ADHD: a meta-analysis, Pediatrics sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports that girls with ADHD have higher rates of anxiety and depression diagnoses than girls without ADHD, and notes that girls generally have higher rates of internalizing psychopathology than boys. The paper does not establish that girls with ADHD are more likely than boys with ADHD to have a comorbid internalizing condition; its meta-analysis compares girls with and without ADHD. (LLM, conf=0.86)
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
- It may state two separate claims as one. 24
- Probably not a substantial claim. 27
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Treatment discontinuation also places individuals with ADHD at higher risk for catastrophic outcomes, such as motor vehicle crashes78,79; criminality, including drug-related crimes77 and violent reoffending76; depression71; interpersonal issues80; and other injuries.81,82”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Not checked — no full text of the sourcecites [78] Chang, 2017, Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes, JAMA Psychiatry source
- Partly supportedcites [79] Chang, 2014, Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study, JAMA Psychiatry sourceExperimental — accuracy not yet measured
Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
- Partly supportedcites [77] Lichtenstein, 2012, Medication for attention deficit-hyperactivity disorder and criminality, N Engl J Med sourceExperimental — accuracy not yet measured
The Abstract Results and Results—Sensitivity analyses report lower criminality rates during ADHD-medication periods, including for substance-related crimes. That supports the criminality and drug-related-crime portion attributed to this paper, but the claim that discontinuation *places* people at higher risk is stronger than the paper’s observational finding; the Discussion cautions that confounding cannot be excluded. The other outcomes in the citing sentence carry separate citations. (LLM, conf=0.85)
- Partly supportedcites [76] Chang, 2016, Association between prescription of major psychotropic medications and violent reoffending after prison release, JAMA sourceExperimental — accuracy not yet measured
The Results and Sensitivity Analyses (page unavailable) associate psychostimulant treatment with lower violent reoffending rates, including among released prisoners diagnosed with ADHD. The claim overstates this as a causal effect of treatment discontinuation in individuals with ADHD generally; the Discussion explicitly says the observational study cannot prove causality. This citation is attached to violent reoffending, not the other listed outcomes. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
Every source the paper cites for this claim was checked and supports it.
In the paper
“As individuals with ADHD enter adolescence, their overt hyperactive and impulsive symptoms tend to decline, whereas their inattentive symptoms tend to persist.13,14”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > ADHD EPIDEMIOLOGY AND SCOPE
What the sources say
- Supportedcites [13] Molina, 2009, The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study, J Am Acad Child Adolesc Psychiatry source
The Discussion reports a decrease in parent- and teacher-rated hyperactivity and impulsivity as the MTA children reached adolescence. The Results (Functioning Relative to the LNCG; page unavailable) report that inattention ratings remained elevated and that inattentive subtype was the most common ADHD diagnosis at eight years. Together, these findings support the stated pattern in this cohort. (LLM, conf=0.87)
- Supportedcites [14] Holbrook, 2016, Persistence of parent-reported ADHD symptoms from childhood through adolescence in a community sample, J Atten Disord source
The Discussion says this study suggests that hyperactive-impulsive symptoms often remit while inattentive symptoms generally persist into adolescence. The Results likewise report declining hyperactive-impulsive symptoms with age and little change in inattentive symptom counts across developmental stages. (LLM, conf=0.94)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It is indicated in prospective studies that patients with ADHD, whether treated or not, are at increased risk for early death, suicide, and increased psychiatric comorbidity, particularly substance use disorders.71,72”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Partly supportedcites [71] Chang, 2016, Medication for attention-deficit/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study, Biol Psychiatry sourceExperimental — accuracy not yet measured
The Introduction (page not provided) says ADHD is associated with high comorbidity, long-term morbidity and mortality, and that youths with ADHD and comorbid depression face greater risk of adverse outcomes, including suicide. It does not establish increased risk of early death or suicide in patients regardless of treatment status, or identify substance use disorders as a particularly increased comorbidity. The Discussion (page not provided) instead mentions substance use disorder in relation to a possible protective effect of medication. (LLM, conf=0.84)
- Partly supportedcites [72] Biederman, 2009, Do stimulants protect against psychiatric disorders in youth with ADHD? A 10-year follow-up study, Pediatrics sourceExperimental — accuracy not yet measured
The Introduction (page unavailable) says ADHD is associated with high rates of psychiatric comorbidity, and the Results (page unavailable) compare subsequent disorders in stimulant-treated and untreated youth. The paper does not report an increased risk of early death or suicide, and substance use disorders were not among the outcomes analyzed. Its results also distinguish treated from untreated youth rather than finding the same psychiatric risk in both groups. (LLM, conf=0.88)
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“The American Psychiatric Association developed the DSM-5 using expert consensus and an expanding research foundation.32”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > KAS 2
What the sources say
- Could not verifycites [32] American Psychiatric Association, 2013 sourceExperimental — accuracy not yet measured
The passages labeled 11 September 2026 discuss WHO guidance on depression, not the development of DSM-5. Searches for “DSM-5,” “expert consensus,” and “research foundation” found no passage in our indexed copy addressing the claim. (LLM, conf=0.77)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Could not verify
Every source the paper cites for this claim was checked and supports it.
In the paper
“The effects diminished by the third year of treatment, but no compensatory rebound growth was observed.110”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Supportedcites [110] Swanson, 2007, Effects of stimulant medication on growth rates across 3 years in the MTA follow-up, J Am Acad Child Adolesc Psychiatry source
The Abstract reports that stimulant-related decreases in growth rates appeared to reach asymptotes within three years, without evidence of growth rebound. The Discussion likewise finds no support for rebound during continued treatment, although the study did not test rebound after medication withdrawal. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The evidence for this behavioral family approach is mixed and less strong than PTBM with preadolescent children92–94”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents
What the sources say
- Not checked — no full text of the sourcecites [92] Barkley, 1992, A comparison of three family therapy programs for treating family conflicts in adolescents with attention-deficit hyperactivity disorder, J Consult Clin Psychol source
- Partly supportedcites [93] Fabiano, 2016, Efficacy of a family-focused intervention for young drivers with attention-deficit hyperactivity disorder, J Consult Clin Psychol sourceExperimental — accuracy not yet measured
The paper says findings for parent-training programs for adolescents with ADHD are mixed (introductory passage), supporting that part of the claim. The Discussion reports long-lasting gains from behavioral parent training in young children, but it does not directly establish that the overall evidence for the adolescent approach is less strong than for PTBM with preadolescent children. Page numbers are unavailable in our copy. (LLM, conf=0.84)
- Partly supportedcites [94] Sibley, 2016, Parent-teen behavior therapy + motivational interviewing for adolescents with ADHD, J Consult Clin Psychol sourceExperimental — accuracy not yet measured
The Discussion reports mixed results for the adolescent parent–teen intervention: several significant benefits, but no effects on five outcomes and variable maintenance at six months. The paper also describes successful clinic-based approaches for younger children, but it does not directly compare the strength of evidence for adolescent behavioral family therapy with PTBM for preadolescent children (page numbers unavailable in our copy). (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Parent and child and adolescent education is an important component in the chronic illness model to ensure cooperation in efforts to achieve appropriate titration, remembering that the parents themselves may be significantly challenged by ADHD.148,149”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KAS 6
What the sources say
- Not matchedcites [148] Wagner, 1998, Chronic disease management: what will it take to improve care for chronic illness?, Effect Clin Pract
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Partly supportedcites [149] Brinkman, 2018, Predictors of medication continuity in children with ADHD, Pediatrics sourceExperimental — accuracy not yet measured
The Discussion (page not available) identifies parent satisfaction with medication information and medication titration as predictors of continuity. A later passage labeled Figure 1 recommends educating families about treatment options and titrating medication. The paper does not establish that parent, child, and adolescent education ensures cooperation with titration, or frame that link as a component of a chronic illness model. (LLM, conf=0.84)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Encouraging strong family-school partnerships helps the ADHD management process, and addressing social determinants of health is essential to these partnerships.145,146”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > School Programming and Supports
What the sources say
- Not checked — no full text of the sourcecites [145] Committee on Pediatric Workforce, 2013, Enhancing pediatric workforce diversity and providing culturally effective pediatric care: implications for practice, education, and policy making, Pediatrics source
- Partly supportedcites [146] Berman, 2018, Screening for poverty and poverty-related social determinants of health, Pediatr Rev sourceExperimental — accuracy not yet measured
The Conclusion (page not available in our copy) urges pediatric providers to address poverty-related social determinants of children’s health and mentions partnerships with community agencies. It does not say that addressing those determinants is essential to family-school partnerships or discuss those partnerships in ADHD management. (LLM, conf=0.78)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Fully addressing systemic barriers requires identifying local, state, and national entities with which to partner to advance solutions and manifest change.156”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > CONCLUSIONS
What the sources say
- Could not verifycites [156] American Academy of Pediatrics, Committee on Child Health Financing, 2012, Scope of health care benefits for children from birth through age 26, Pediatrics sourceExperimental — accuracy not yet measured
The ESSENTIAL BACKGROUND section discusses access to pediatric health benefits and coordination of care, but not partnering with local, state, and national entities to address systemic barriers. Searches for that language and for partnerships or advocacy to overcome barriers found no passage addressing the claim. Page numbers were not available in our copy. (LLM, conf=0.75)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
- Could not verify
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The PoCA provides recommendations for implementing the guideline steps, although there is less evidence for the PoCA than for the guidelines.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > PoCA for the Diagnosis and Treatment of Children and Adolescents With ADHD
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The subcommittee members’ potential conflicts were identified and taken into consideration in the group’s deliberations.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > METHODOLOGY
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“There is some evidence that African American and Latino children are less likely to have ADHD diagnosed and are less likely to be treated for ADHD.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Systems Barriers to the Care of Children and Adolescents With ADHD
What the sources say
- Not checked — no full text of the sourcecites [3] Pastor, 2005, Racial and ethnic differences in ADHD and LD in young school-age children: parental reports in the National Health Interview Survey, Public Health Rep source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“No conflicts prevented subcommittee member participation on the guidelines.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > METHODOLOGY
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The procedures recommended in this guideline necessitate spending more time with patients and their families, developing a care management system of contacts with school and other community stakeholders, and providing continuous, coordinated care to the patient and his or her family.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Systems Barriers to the Care of Children and Adolescents With ADHD
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this revised guideline and accompanying PoCA, we recognize that evaluation, diagnosis, and treatment are a continuous process.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > PoCA for the Diagnosis and Treatment of Children and Adolescents With ADHD
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“As noted, ADHD is the most common neurobehavioral disorder of childhood, occurring in approximately 7% to 8% of children and youth.8,18,28,29”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > KAS 1
What the sources say
- Not checked — no full text of the sourcecites [8] Thomas, 2015, Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis, Pediatrics source
- Not checked yetcites [18] Centers for Disease Control and Prevention (CDC), 2005, Mental health in the United States. Prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder--United States, 2003, MMWR Morb Mortal Wkly Rep
- Not checked — no full text of the sourcecites [28] Visser, 2007, National estimates and factors associated with medication treatment for childhood attention-deficit/hyperactivity disorder, Pediatrics source
- Not checked yetcites [29] Centers for Disease Control and Prevention (CDC), 2010, Increasing prevalence of parent-reported attention-deficit/hyperactivity disorder among children–United States, 2003 and 2007, MMWR Morb Mortal Wkly Rep
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Although the chronic illness model has not been specifically studied in children and adolescents with ADHD, it has been effective for other chronic conditions, such as asthma.68”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday) > KAS 4
What the sources say
- Not checked yetcites [68] Medical Home Initiatives for Children With Special Needs Project Advisory Committee. American Academy of Pediatrics, 2002, The medical home, Pediatrics
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Under this format, studies were only included in the review when they met a variety of criteria designed to ensure the research was based on a strong methodology that yielded confidence in its conclusions.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Evidence Review
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The subcommittee reached consensus on the evidence, which was then used to develop the clinical practice guideline’s KASs.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Guideline Recommendations and Key Action Statements
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“A variety of other behavioral, developmental, and physical conditions can be comorbid in children and adolescents who are evaluated for ADHD, including emotional or behavioral conditions or a history of these problems.”
- Also stated in: § KAS 3 · plain
“These include but are not limited to learning disabilities, language disorder, disruptive behavior, anxiety, mood disorders, tic disorders, seizures, autism spectrum disorder, developmental coordination disorder, and sleep disorders.50–66”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > KAS 3
What the sources say
- Not checked — no full text of the sourcecites [50] Rowland, 2002, The epidemiology of attention-deficit/hyperactivity disorder (ADHD): a public health view, Ment Retard Dev Disabil Res Rev source
- Not checked — no full text of the sourcecites [51] Cuffe, 2005, Prevalence and correlates of ADHD symptoms in the national health interview survey, J Atten Disord source
- Not checked — no full text of the sourcecites [52] Pastor, 2008, Diagnosed attention deficit hyperactivity disorder and learning disability: United States, 2004-2006, Vital Health Stat 10
- Not checked — no full text of the sourcecites [53] Biederman, 2004, Further evidence of unique developmental phenotypic correlates of pediatric bipolar disorder: findings from a large sample of clinically referred preadolescent children assessed over the last 7 years, J Affect Disord source
- Not checked — no full text of the sourcecites [54] Biederman, 2005, Absence of gender effects on attention deficit hyperactivity disorder: findings in nonreferred subjects, Am J Psychiatry source
- Not checked — no full text of the sourcecites [55] Biederman, 2008, New insights into the comorbidity between ADHD and major depression in adolescent and young adult females, J Am Acad Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [56] Biederman, 2008, Long-term, open-label extension study of guanfacine extended release in children and adolescents with ADHD, CNS Spectr source
- Not checked — no full text of the sourcecites [57] Crabtree, 2003, Clinical and parental assessment of sleep in children with attention-deficit/hyperactivity disorder referred to a pediatric sleep medicine center, Clin Pediatr (Phila) source
- Not checked — no full text of the sourcecites [58] LeBourgeois, 2004, Snoring, sleep quality, and sleepiness across attention-deficit/hyperactivity disorder subtypes, Sleep source
- Not checked — no full text of the sourcecites [59] Chan, 2002, Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the Medical Expenditure Panel Survey, Arch Pediatr Adolesc Med source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Also stated in: § KAS 3 · plain
In the paper
“The AAP policy statement, “Classifying Recommendations for Clinical Practice Guidelines,” was followed in designating aggregate evidence quality levels for the available evidence (see Fig 1).27”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Guideline Recommendations and Key Action Statements
What the sources say
- Not checked — no full text of the sourcecites [27] American Academy of Pediatrics Steering Committee on Quality Improvement and Management, 2004, Classifying recommendations for clinical practice guidelines, Pediatrics source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, the intervention’s results may inform the subsequent diagnostic evaluation.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Referral to an early intervention program or enrolling in a PTBM program can help provide information about the child’s behavior in other settings or with other observers.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Preschool-Aged Children (Age 4 Years to the Sixth Birthday)
plainconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The guidelines and PoCA underwent extensive peer review by more than 30 internal stakeholders (eg, AAP committees, sections, councils, and task forces) and external stakeholder groups identified by the subcommittee.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Peer Review
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The subcommittee members with the most epidemiological experience assessed the strength of each recommendation and the quality of evidence supporting each draft KAS.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Guideline Recommendations and Key Action Statements
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“PTBM has been modified to include the parents and adolescents in sessions together to develop a behavioral contract and improve parent-adolescent communication and problem-solving (see above).91”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents
What the sources say
- Not checked yetcites [91] Robin, 1989
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In addition, preschool programs (such as Head Start) and ADHD-focused organizations (such as CHADD84) can also provide behavioral supports.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Recommendations for the Treatment of Children and Adolescents With ADHD: KAS 5a, 5b, and 5c > KAS 5a
What the sources say
- Not matchedcites [84] Children and Adults with Attention-Deficit/Hyperactivity Disorder. CHADD. Available at: www.chadd.org. Accessed September 8, 2019
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The evidence is particularly strong for stimulant medications; it is sufficient, but not as strong, for atomoxetine, extended-release guanfacine, and extended-release clonidine, in that order (see the Treatment section, and see the PoCA for more information on implementation).”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Recommendations for the Treatment of Children and Adolescents With ADHD: KAS 5a, 5b, and 5c > KAS 5b
boosted- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, the current evidence supporting treatment of ADHD with eTNS is sparse and in no way approaches the robust strength of evidence documented for established medication and behavioral treatments for ADHD; therefore, it cannot be recommended as a treatment of ADHD without considerably more extensive study on its efficacy and safety.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Psychosocial Treatments
plainn = 30- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Children with inattention or hyperactivity/impulsivity at the problem level, as well as their families, may also benefit from the chronic illness and medical home principles.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Inattention or Hyperactivity/Impulsivity (Problem Level)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“Although it was limited to children who had moderate-to-severe dysfunction, the largest multisite study of methylphenidate use in preschool-aged children revealed symptom improvements after PTBM alone.83”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Recommendations for the Treatment of Children and Adolescents With ADHD: KAS 5a, 5b, and 5c > KAS 5a
What the sources say
- Not checked — no full text of the sourcecites [83] Greenhill, 2006, Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD, J Am Acad Child Adolesc Psychiatry source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Overall, the current evidence supporting treatment of ADHD with eTNS is sparse and in no way approaches the robust strength of evidence documented for established medication and behavioral treatments for ADHD; therefore, it cannot be recommended as a treatment of ADHD without considerably more extensive study on its efficacy and safety.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Psychosocial Treatments
plainn = 30- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: There is no long-term safety and efficacy evidence for eTNS.
In the paper
“In addition, the risks of mood and anxiety disorders and risky sexual behaviors increase during adolescence, as do the risks of intentional self-harm and suicidal behaviors.31”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday)
What the sources say
- Not checked — no full text of the sourcecites [31] Wolraich, 2005, Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications, Pediatrics source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Therefore, the DSM-PC cannot be used as a definitive source for diagnostic codes related to ADHD and comorbid conditions, although it can be used conceptually as a resource for enriching the understanding of problem-level manifestations.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Inattention or Hyperactivity/impulsivity (Problem Level)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Rests on an assumption: The DSM-PC was published in 1995, and it has not been revised to be compatible with the DSM-5.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“As noted, all 4 are common comorbid conditions that affect the treatment approach.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Longer-acting or late-afternoon, short-acting medications may be helpful in this regard.138”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Special Circumstances: Adolescents (Age 12 Years to the 18th Birthday)
What the sources say
- Not checked — no full text of the sourcecites [138] Cox, 2006, Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder, Pediatrics source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The steps required to sustain appropriate treatments and achieve successful long-term outcomes remain challenging, however.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > CONCLUSIONS
plain- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
In the paper
“Finally the combination of medication management and behavioral therapy allowed for the use of lower stimulant dosages, possibly reducing the risk of adverse effects.141”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Combination Treatments
What the sources say
- Not checked — no full text of the sourcecites [141] Pelham, 1999, Psychosocial and combined treatments for ADHD, Ment Retard Dev Disabil Res Rev source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Authors of other reports suggest that more than 90% of patients will have a beneficial response to 1 of the psychostimulants if a range of medications from both the methylphenidate and amphetamine and/or dextroamphetamine classes are tried.147”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KAS 6
What the sources say
- Not checked — no full text of the sourcecites [147] Solanto, 1998, Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration, Behav Brain Res source
hedgeddirect- Asserted: fails — The authors may not put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The authors may not put it forward as true. The paper’s conclusions may not depend on it.
In the paper
“Encouraging strong family-school partnerships helps the ADHD management process.142”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > School Programming and Supports
What the sources say
- Not checked — no full text of the sourcecites [142] Homer, 2008, A review of the evidence for the medical home for children with special health care needs, Pediatrics source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Stimulant medications can be effectively titrated on a 7-day basis, but in urgent situations, they may be effectively titrated in as few as 3 days.140”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KAS 6
What the sources say
- Not checked — no full text of the sourcecites [140] Jensen, 2001, Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers, J Dev Behav Pediatr source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The SDBP is developing a guideline to address such complex cases and aid pediatricians and other PCCs to manage these cases; the SDBP currently expects to publish this document in 2019.67”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > IMPLEMENTATION: PREPARING THE PRACTICE
What the sources say
- Not matchedcites [67] Society for Developmental and Behavioral Pediatrics. ADHD special interest group. Available at: www.sdbp.org/committees/sig-adhd.cfm. Accessed September 8, 2019
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Not matched
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Full implementation of the guideline’s KASs, the PoCA, and the recommendations to address barriers to care may require changes in office procedures and the identification of community resources.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > CONCLUSIONS
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“Additional adverse effects of atomoxetine include initial somnolence and gastrointestinal tract symptoms, particularly if the dosage is increased too rapidly, and decreased appetite.119–122”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > Medication for ADHD > Side Effects
What the sources say
- Not checked — no full text of the sourcecites [119] Garnock-Jones, 2009, Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents, Paediatr Drugs source
- Not checked — no full text of the sourcecites [120] Reed, 2016, The safety of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a comprehensive review of over a decade of research, CNS Drugs source
- Not checked — no full text of the sourcecites [121] Bangs, 2008, Meta-analysis of suicide-related behavior events in patients treated with atomoxetine, J Am Acad Child Adolesc Psychiatry source
- Not checked — no full text of the sourcecites [122] Bangs, 2008, Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder, Drug Saf source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Evidence is clear with regard to the legitimacy of the diagnosis of ADHD and the appropriate diagnostic criteria and procedures required to establish a diagnosis, identify comorbid conditions, and effectively treat with both psychosocial and pharmacologic interventions.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > CONCLUSIONS
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper relies on this without support.
Since the release of the 2011 guideline, the DSM has been revised to the fifth edition, and new ADHD-related research has been published.
“Since the release of the 2011 guideline, the Diagnostic and Statistical Manual of Mental Disorders has been revised to the fifth edition, and new ADHD-related research has been published.”
The paper relies on this without support.
ADHD is one of the most common neurobehavioral disorders of childhood and can profoundly affect children’s academic achievement, well-being, and social interactions.
“Attention-deficit/hyperactivity disorder (ADHD) is one of the most common neurobehavioral disorders of childhood and can profoundly affect children’s academic achievement, well-being, and social interactions.”
The paper relies on this without support.
Symptoms of ADHD occur in childhood, and most children with ADHD will continue to have symptoms and impairment through adolescence and into adulthood.
“Symptoms of ADHD occur in childhood, and most children with ADHD will continue to have symptoms and impairment through adolescence and into adulthood.”
The paper relies on this without support.
The DSM-5 system is used by professionals in psychiatry, psychology, health care systems, and primary care; it is also well established with third-party payers.
“The DSM-5 system is used by professionals in psychiatry, psychology, health care systems, and primary care; it is also well established with third-party payers.”
The paper relies on this without support.
The DSM-5 classification criteria are based on the best available evidence for ADHD diagnosis and are the standard most frequently used by clinicians and researchers to render the diagnosis and document its appropriateness for a given child.
“As with the previous guideline recommendations, the DSM-5 classification criteria are based on the best available evidence for ADHD diagnosis and are the standard most frequently used by clinicians and researchers to render the diagnosis and document its appropriateness for a given child.”
The paper relies on this without support.
There are minimal changes in the specific behaviors from the DSM-IV, on which all the other DSM-based ADHD rating scales obtained normative data.
“There are, however, minimal changes in the specific behaviors from the DSM-IV, on which all the other DSM-based ADHD rating scales obtained normative data.”
The paper relies on this without support.
Both the ADHD Rating Scale-IV and the Conners Rating Scale have preschool-age normative data based on the DSM-IV.
“Both the ADHD Rating Scale-IV and the Conners Rating Scale have preschool-age normative data based on the DSM-IV.”
The paper relies on this without support.
The specific behaviors in the DSM-5 criteria for ADHD are the same for all children younger than 18 years and are only minimally different from the DSM-IV.
“The specific behaviors in the DSM-5 criteria for ADHD are the same for all children younger than 18 years (ie, preschool-aged children, elementary and middle school-aged children, and adolescents) and are only minimally different from the DSM-IV.”
The paper relies on this without support.
PTBM helps parents learn age-appropriate developmental expectations, behaviors that strengthen the parent-child relationship, and specific management skills for problem behaviors.
“This type of training helps parents learn age-appropriate developmental expectations, behaviors that strengthen the parent-child relationship, and specific management skills for problem behaviors.”
The paper relies on this without support.
PTBM has documented effectiveness with a wide variety of problem behaviors, regardless of etiology.
“Clinicians do not need to have made an ADHD diagnosis before recommending PTBM because PTBM has documented effectiveness with a wide variety of problem behaviors, regardless of etiology.”
The paper relies on this without support.
Obtaining teacher reports for adolescents is often more challenging than for younger children because many adolescents have multiple teachers.
“Obtaining teacher reports for adolescents is often more challenging than for younger children because many adolescents have multiple teachers.”
The paper relies on this without support.
An adolescent’s parents may have less opportunity to observe their child’s behaviors than they did when the child was younger.
“Likewise, an adolescent’s parents may have less opportunity to observe their child’s behaviors than they did when the child was younger.”
The paper relies on this without support.
Some problems experienced by children with ADHD are less obvious in adolescents than in younger children because adolescents are less likely to exhibit overt hyperactive behavior.
“Furthermore, some problems experienced by children with ADHD are less obvious in adolescents than in younger children because adolescents are less likely to exhibit overt hyperactive behavior”
The paper relies on this without support.
Variability in ratings is to be expected because adolescents’ behavior often varies between different classrooms and with different teachers.
“Variability in ratings is to be expected because adolescents’ behavior often varies between different classrooms and with different teachers.”
The paper relies on this without support.
Certain substances, such as marijuana, can have effects that mimic ADHD.
“Certain substances, such as marijuana, can have effects that mimic ADHD”
The paper relies on this without support.
Trauma experiences, posttraumatic stress disorder, and toxic stress are additional comorbidities and risk factors of concern.
“Trauma experiences, posttraumatic stress disorder, and toxic stress are additional comorbidities and risk factors of concern.”
The paper relies on this without support.
Teachers, parents, and child health professionals typically encounter children who demonstrate behaviors relating to activity level, impulsivity, and inattention but who do not fully meet DSM-5 criteria.
“Teachers, parents, and child health professionals typically encounter children who demonstrate behaviors relating to activity level, impulsivity, and inattention but who do not fully meet DSM-5 criteria.”
The paper relies on this without support.
These symptoms may suggest other problems that mimic ADHD.
“Also consider that these symptoms may suggest other problems that mimic ADHD.”
The paper relies on this without support.
Behavioral interventions, such as PTBM, are often beneficial for children with hyperactive/impulsive behaviors who do not meet full diagnostic criteria for ADHD.
“Behavioral interventions, such as PTBM, are often beneficial for children with hyperactive/impulsive behaviors who do not meet full diagnostic criteria for ADHD.”
The paper relies on this without support.
The DSM-PC was published in 1995, and it has not been revised to be compatible with the DSM-5.
“The DSM-PC was published in 1995, however, and it has not been revised to be compatible with the DSM-5.”
The paper relies on this without support.
In some cases, the presence of a comorbid condition will alter the treatment of ADHD.
“In some cases, the presence of a comorbid condition will alter the treatment of ADHD.”
The paper relies on this without support.
Available treatments address symptoms and function but are usually not curative.
“Available treatments address symptoms and function but are usually not curative.”
The paper relies on this without support.
This communication can be difficult to achieve.
“This communication can be difficult to achieve and is discussed in both the PoCA and the section on systemic barriers to the care of children and adolescents with ADHD in the Supplemental Information, as is the medical home model.69”
The paper relies on this without support.
PTBM programs for preschool-aged children are typically group programs and, although they are not always paid for by health insurance, they may be relatively low cost.
“PTBM programs for preschool-aged children are typically group programs and, although they are not always paid for by health insurance, they may be relatively low cost.”
The paper relies on this without support.
One evidence-based PTBM, parent-child interaction therapy, is a dyadic therapy for parent and child.
“One evidence-based PTBM, parent-child interaction therapy, is a dyadic therapy for parent and child.”
The paper relies on this without support.
Other stimulant or nonstimulant medications have not been adequately studied in children in this age group with ADHD.
“Other stimulant or nonstimulant medications have not been adequately studied in children in this age group with ADHD.”
The paper relies on this without support.
The medical home and chronic illness approach may be particularly beneficial for parents who also have ADHD themselves.
“The medical home and chronic illness approach may be particularly beneficial for parents who also have ADHD themselves.”
The paper relies on this without support.
Stimulants have a stronger immediate effect on the 18 core symptoms of ADHD than behavior therapy in most studies comparing them.
“Most studies comparing behavior therapy to stimulants indicate that stimulants have a stronger immediate effect on the 18 core symptoms of ADHD.”
The paper relies on this without support.
Parents were more satisfied with the effect of behavioral therapy than with stimulants.
“Parents, however, were more satisfied with the effect of behavioral therapy, which addresses symptoms and functions in addition to ADHD’s core symptoms.”
The paper relies on this without support.
The positive effects of behavioral therapies tend to persist, whereas the positive effects of medication cease when medication stops.
“The positive effects of behavioral therapies tend to persist, but the positive effects of medication cease when medication stops.”
The paper relies on this without support.
Some nonmedication treatments for ADHD-related problems have too little evidence to recommend them or have been found to have little or no benefit, including mindfulness, cognitive training, diet modification, EEG biofeedback, and supportive counseling.
“Some nonmedication treatments for ADHD-related problems have either too little evidence to recommend them or have been found to have little or no benefit. These include mindfulness, cognitive training, diet modification, EEG biofeedback, and supportive counseling.”
The paper relies on this without support.
The suggestion that cannabidiol oil has any effect on ADHD is anecdotal and has not been subjected to rigorous study.
“The suggestion that cannabidiol oil has any effect on ADHD is anecdotal and has not been subjected to rigorous study.”
The paper relies on this without support.
There is no long-term safety and efficacy evidence for eTNS.
“To date, there is no long-term safety and efficacy evidence for eTNS.”
The paper relies on this without support.
Much less research has been published on psychosocial treatments with adolescents than with younger children.
“Much less research has been published on psychosocial treatments with adolescents than with younger children.”
The paper relies on this without support.
Meaningful improvements in functioning have not been reported from cognitive behavioral approaches for adolescents.
“Meaningful improvements in functioning have not been reported from cognitive behavioral approaches.”
The paper relies on this without support.
None of the nonstimulants have FDA approval for use in preschool-aged children.
“None of the nonstimulants have FDA approval for use in preschool-aged children.”
The paper relies on this without support.
The effect size for nonstimulants is 0.7.
“The effect size for stimulants is 1.0 and for nonstimulants is 0.7.”
The paper relies on this without support.
An individual’s response to methylphenidate versus amphetamine is idiosyncratic, with approximately 40% responding to both and about 40% responding to only one.
“An individual’s response to methylphenidate verses amphetamine is idiosyncratic, with approximately 40% responding to both and about 40% responding to only 1.”
The paper relies on this without support.
The subtype of ADHD does not appear to be a predictor of response to a specific agent.
“The subtype of ADHD does not appear to be a predictor of response to a specific agent.”
The paper relies on this without support.
The evidence base supporting norepinephrine reuptake inhibitors and α-2 adrenergic agonists is considerably less than that for stimulants, although it was adequate for FDA approval.
“Norepinephrine reuptake inhibitors and α-2 adrenergic agonists are newer medications, so, in general, the evidence base supporting them is considerably less than that for stimulants, although it was adequate for FDA approval.”
The paper relies on this without support.
Pharmacogenetic tests may cost thousands of dollars and are typically not covered by insurance.
“In addition, these tests may cost thousands of dollars and are typically not covered by insurance.”
The paper relies on this without support.
Stimulants’ most common short-term adverse effects are appetite loss, abdominal pain, headaches, and sleep disturbance.
“Stimulants’ most common short-term adverse effects are appetite loss, abdominal pain, headaches, and sleep disturbance.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > KASS FOR THE EVALUATION, DIAGNOSIS, TREATMENT, AND MONITORING OF CHILDREN AND ADOLESCENTS WITH ADHD > Special Circumstances: Inattention or Hyperactivity/impulsivity (Problem Level)
“The DSM-PC was published in 1995, however, and it has not been revised to be compatible with the DSM-5.”
§ Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents > References
“49. Wolraich ML, Felice ME, Drotar DD. The Classification of Child and Adolescent Mental Conditions in Primary Care: Diagnostic and Statistical Manual for Primary Care (DSM-PC), Child and Adolescent Version. Elk Grove Village, IL: American Academy of Pediatrics; 1996”
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
(1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1073 · Cited by 3,372
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Self-citationChronic disease management: what will it take to improve care for chronic illness?
Eh, W. (1998) · PubMed · Cited by 2,095
Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015) · Pediatrics · doi:10.1542/peds.2014-3482 · Cited by 1,976 · cited 2×
“7 Authors of a recent meta-analysis calculated a pooled worldwide ADHD prevalence of 7.2% among children 8 ; estimates from some community-based samples are somewhat higher, at 8.7% to 15.5%.”
InfluentialMolina, B. S. G., Hinshaw, S. P., Swanson, J. M., Arnold, L. E., Vitiello, B., Jensen, P. S., Epstein, J. N., Hoza, B., Hechtman, L., Abikoff, H. B., et al. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31819c23d0 · Cited by 1,182 · cited 1×
“As individuals with ADHD enter adolescence, their overt hyperactive and impulsive symptoms tend to decline, whereas their inattentive symptoms tend to persist.(13,14) Learning and language problems are common comorbid conditions with ADHD.”
Danielson, M. L., Bitsko, R. H., Ghandour, R. M., Holbrook, J. R., Kogan, M. D., & Blumberg, S. J. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2017.1417860 · Cited by 1,181 · cited 17×
“5,6 To assist pediatricians and other PCCs in overcoming such obstacles, the companion article on systemic barriers to the care of children and adolescents with ADHD reviews the barriers and makes recommendations to address them to enhance care for children and adolescents with ADHD.”
InfluentialGender Differences in ADHD: A Meta-Analysis and Critical Review
GAUB, M., & CARLSON, C. L. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199708000-00011 · Cited by 1,117 · cited 1×
“Boys are more likely to exhibit externalizing conditions like oppositional defiant disorder or conduct disorder.(17,19,20) Recent research has established that girls with ADHD are more likely than boys to have a comorbid internalizing condition like anxiety or depression.”
Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder
Pelham, W. E., & Fabiano, G. A. (2008) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374410701818681 · Cited by 917 · cited 1×
“26 Under this format, studies were only included in the review when they met a variety of criteria designed to ensure the research was based on a strong methodology that yielded con fi dence in its conclusions.”
Misuse and Diversion of Stimulants Prescribed for ADHD: A Systematic Review of the Literature
WILENS, T. E., ADLER, L. A., ADAMS, J., SGAMBATI, S., ROTROSEN, J., SAWTELLE, R., UTZINGER, L., & FUSILLO, S. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815a56f1 · Cited by 824
(2002) · PEDIATRICS · doi:10.1542/peds.110.1.184 · Cited by 799
Empirically supported psychosocial treatments for attention deficit hyperactivity disorder
Pelham Jr, W. E., Wheeler, T., & Chronis, A. (1998) · Journal of Clinical Child Psychology · doi:10.1207/s15374424jccp2702_6 · Cited by 755
Evans, S. W., Owens, J. S., & Bunford, N. (2014) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2013.850700 · Cited by 728 · cited 7×
“established treatments with preadolescent children.(25,87,88) Most”
InfluentialSelf-citationSolanto, M. V. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(97)00175-7 · Cited by 677 · cited 2×
“147 Of note, children in the MTA study who received care in the community as usual, either from a clinician they chose or to whom their family had access, showed less bene fi cial results compared with children who received optimal medication management.”
Medication for Attention Deficit–Hyperactivity Disorder and Criminality
Lichtenstein, P., Halldner, L., Zetterqvist, J., Sjölander, A., Serlachius, E., Fazel, S., Långström, N., & Larsson, H. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203241 · Cited by 611
Michelson, D., Allen, A. J., Busner, J., Casat, C., Dunn, D., Kratochvil, C., Newcorn, J., Sallee, F. R., Sangal, R. B., Saylor, K., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1896 · Cited by 599 · cited 1×
“140 Authors of other reports suggest that more than 90% of patients will have a bene fi cial response to 1 of the psychostimulants if a range of medications from both the methylphenidate and amphetamine and/or dextroamphetamine classes”
JENSEN, P. S., HINSHAW, S. P., SWANSON, J. M., GREENHILL, L. L., CONNERS, C. K., ARNOLD, L. E., ABIKOFF, H. B., ELLIOTT, G., HECHTMAN, L., HOZA, B., et al. (2001) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200102000-00008 · Cited by 591 · cited 4×
“The results further emphasize the need to treat ADHD as a chronic illness and provide continuity of care and, where possible, provide a medical home.(140)”
InfluentialPatterns of Comorbidity, Functioning, and Service Use for US Children With ADHD, 2007
Larson, K., Russ, S. A., Kahn, R. S., & Halfon, N. (2011) · Pediatrics · doi:10.1542/peds.2010-0165 · Cited by 580
The epidemiology of attention‐deficit/hyperactivity disorder (ADHD): A public health view
Rowland, A. S., Lesesne, C. A., & Abramowitz, A. J. (2002) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.10036 · Cited by 495
Evans, S. W., Owens, J. S., Wymbs, B. T., & Ray, A. R. (2018) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2017.1390757 · Cited by 477 · cited 3×
“Evans et al 25 Obtaining teacher reports for adolescents is often more challenging than for younger children because many adolescents have multiple teachers.”
InfluentialSelf-citationEfficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD
GREENHILL, L., KOLLINS, S., ABIKOFF, H., MCCRACKEN, J., RIDDLE, M., SWANSON, J., MCGOUGH, J., WIGAL, S., WIGAL, T., VITIELLO, B., et al. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000235077.32661.61 · Cited by 467 · cited 20×
“5,6 To assist pediatricians and other PCCs in overcoming such obstacles, the companion article on systemic barriers to the care of children and adolescents with ADHD reviews the barriers and makes recommendations to address them to enhance care for children and adolescents with ADHD.”
Influential(2010) · PsycEXTRA Dataset · doi:10.1037/e664852010-002 · Cited by 456
PLISZKA, S. R., CRISMON, M. L., HUGHES, C. W., CORNERS, C. K., EMSLIE, G. J., JENSEN, P. S., McCRACKEN, J. T., SWANSON, J. M., & LOPEZ, M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000215326.51175.eb · Cited by 442
Validity of DSM‐IV Attention‐Deficit/Hyperactivity Disorder for Younger Children
LAHEY, B. B., PELHAM, W. E., STEIN, M. A., LONEY, J., TRAPANI, C., NUGENT, K., KIPP, H., SCHMIDT, E., LEE, S., CALE, M., et al. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199807000-00008 · Cited by 422
SONUGA-BARKE, E. J. S., DALEY, D., THOMPSON, M., LAVER-BRADBURY, C., & WEEKS, A. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200104000-00008 · Cited by 415
ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults
Cooper, W. O., Habel, L. A., Sox, C. M., Chan, K. A., Arbogast, P. G., Cheetham, T. C., Murray, K. T., Quinn, V. P., Stein, C. M., Callahan, S. T., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1110212 · Cited by 411
Sleep Problems in Children With Attention-Deficit/Hyperactivity Disorder
Sung, V., Hiscock, H., Sciberras, E., & Efron, D. (2008) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.162.4.336 · Cited by 407
Wolraich, M. L., Wibbelsman, C. J., Brown, T. E., Evans, S. W., Gotlieb, E. M., Knight, J. R., Ross, E. C., Shubiner, H. H., Wender, E. H., & Wilens, T. (2005) · Pediatrics · doi:10.1542/peds.2004-1959 · Cited by 404 · cited 2×
“None.”
Self-citationMortality, ADHD, and Psychosocial Adversity in Adults With Childhood ADHD: A Prospective Study
Barbaresi, W. J., Colligan, R. C., Weaver, A. L., Voigt, R. G., Killian, J. M., & Katusic, S. K. (2013) · Pediatrics · doi:10.1542/peds.2012-2354 · Cited by 401 · cited 1×
“70 It is indicated in prospective studies that patients with ADHD, whether treated or not, are at increased risk for early death, suicide, and increased psychiatric The KASs are presented, followed by information on medication, psychosocial treatments, and special circumstances.”
Garnock-Jones, K. P., & Keating, G. M. (2009) · Pediatric Drugs · doi:10.2165/00148581-200911030-00005 · Cited by 392
A Review of the Evidence for the Medical Home for Children With Special Health Care Needs
Homer, C. J., Klatka, K., Romm, D., Kuhlthau, K., Bloom, S., Newacheck, P., Van Cleave, J., & Perrin, J. M. (2008) · Pediatrics · doi:10.1542/peds.2007-3762 · Cited by 373
Keenan, K., & Wakschlag, L. S. (2000) · Journal of Abnormal Child Psychology · doi:10.1023/a:1005118000977 · Cited by 341
Cortese, S., Holtmann, M., Banaschewski, T., Buitelaar, J., Coghill, D., Danckaerts, M., Dittmann, R. W., Graham, J., Taylor, E., Sergeant, J., et al. (2013) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12036 · Cited by 336
Newcorn, J. H., Kratochvil, C. J., Allen, A. J., Casat, C. D., Ruff, D. D., Moore, R. J., Michelson, D., & Atomoxetine/Methylphenidate Comparative Study Group (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05091676 · Cited by 336
Barkley, R. A., & Cox, D. (2007) · Journal of Safety Research · doi:10.1016/j.jsr.2006.09.004 · Cited by 335 · cited 1×
“Given the risks of driving for adolescents with ADHD, including crashes and motor vehicle violations, special concern should be taken to provide medication coverage for symptom control while driving.(79,136,137) Longer-acting or lateafternoon, short-acting medications may be helpful in this regard.”
(2008) · PubMed · Cited by 334
The Future of Pediatrics: Mental Health Competencies for Pediatric Primary Care
(2009) · PEDIATRICS · doi:10.1542/peds.2009-1061 · Cited by 333
BIEDERMAN, J., BALL, S. W., MONUTEAUX, M. C., MICK, E., SPENCER, T. J., McCREARY, M., COTE, M., & FARAONE, S. V. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31816429d3 · Cited by 331
Understanding Attention-Deficit/Hyperactivity Disorder from Childhood to Adulthood
Wilens, T. E., & Spencer, T. J. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.09.2206 · Cited by 324
Effects of Stimulant Medication on Growth Rates Across 3 Years in the MTA Follow-up
SWANSON, J. M., ELLIOTT, G. R., GREENHILL, L. L., WIGAL, T., ARNOLD, L. E., VITIELLO, B., HECHTMAN, L., EPSTEIN, J. N., PELHAM, W. E., ABIKOFF, H. B., et al. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3180686d7e · Cited by 323 · cited 3×
“The Multimodal Treatment of Attention Deficit Hyperactivity Disorder (MTA) study results identified stimulants as having a more persistent effect on decreasing growth velocity compared to most previous studies.(110) Diminished growth was in the range of 1 to 2 cm from predicted adult height.”
InfluentialClassifying Recommendations for Clinical Practice Guidelines
Steering Committee on Quality Improvement and Management (2004) · Pediatrics · doi:10.1542/peds.2004-1260 · Cited by 322
Tic disorders and ADHD: answers from a world-wide clinical dataset on Tourette syndrome
Freeman, R. D., & Tourette Syndrome International Database Consortium (2007) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-007-1003-7 · Cited by 318
Biederman, J., Melmed, R. D., Patel, A., McBurnett, K., Konow, J., Lyne, A., Scherer, N., & for the SPD503 Study Group (2008) · Pediatrics · doi:10.1542/peds.2006-3695 · Cited by 317
Sallee, F. R., Lyne, A., Wigal, T., & McGough, J. J. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.0080 · Cited by 306 · cited 1×
“140 Authors of other reports suggest that more than 90% of patients will have a bene fi cial response to 1 of the psychostimulants if a range of medications from both the methylphenidate and amphetamine and/or dextroamphetamine classes”
Chang, Z., Lichtenstein, P., D’Onofrio, B. M., Sjölander, A., & Larsson, H. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.4174 · Cited by 293 · cited 1×
“Given the risks of driving for adolescents with ADHD, including crashes and motor vehicle violations, special concern should be taken to provide medication coverage for symptom control while driving.(79,136,137) Longer-acting or lateafternoon, short-acting medications may be helpful in this regard.”
Barkley, R. A., Guevremont, D. C., Anastopoulos, A. D., & Fletcher, K. E. (1992) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.60.3.450 · Cited by 290 · cited 1×
“It does not qualify under an IEP unless its severity impairs the child ’ s ability to learn.”
Biederman, J., Kwon, A., Aleardi, M., Chouinard, V.-A., Marino, T., Cole, H., Mick, E., & Faraone, S. V. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1083 · Cited by 285
Defining ADHD symptom persistence in adulthood: optimizing sensitivity and specificity
Sibley, M. H., Swanson, J. M., Arnold, L. E., Hechtman, L. T., Owens, E. B., Stehli, A., Abikoff, H., Hinshaw, S. P., Molina, B. S. G., Mitchell, J. T., et al. (2017) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.12620 · Cited by 274
Prevalence and Correlates of ADHD Symptoms in the National Health Interview Survey
Cuffe, S. P., Moore, C. G., & McKeown, R. E. (2005) · Journal of Attention Disorders · doi:10.1177/1087054705280413 · Cited by 272
Biederman, J., Melmed, R. D., Patel, A., McBurnett, K., Donahue, J., & Lyne, A. (2008) · CNS Spectrums · doi:10.1017/s1092852900017107 · Cited by 270
Combining Parent and Child Training for Young Children with ADHD
Webster-Stratton, C. H., Reid, M. J., & Beauchaine, T. (2011) · Journal of Clinical Child & Adolescent Psychology · doi:10.1080/15374416.2011.546044 · Cited by 265 · cited 1×
“established treatments with preadolescent children.(25,87,88) Most”
Illicit use of psychostimulants among college students: A preliminary study
Low, K. G., & Gendaszek, A. E. (2002) · Psychology, Health & Medicine · doi:10.1080/13548500220139386 · Cited by 264 · cited 1×
“In addition, diversion of ADHD medication (ie, its use for something other than its intended medical purposes) is a special concern among adolescents.(135) Clinicians should monitor the adolescent’s symptoms and prescription refill requests for signs of misuse or diversion of ADHD medication, including by parents, cla…”
Sudden Death and Use of Stimulant Medications in Youths
Gould, M. S., Walsh, B. T., Munfakh, J. L., Kleinman, M., Duan, N., Olfson, M., Greenhill, L., & Cooper, T. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040472 · Cited by 253
Do Stimulants Protect Against Psychiatric Disorders in Youth With ADHD? A 10-Year Follow-up Study
Biederman, J., Monuteaux, M. C., Spencer, T., Wilens, T. E., & Faraone, S. V. (2009) · Pediatrics · doi:10.1542/peds.2008-3347 · Cited by 246 · cited 1×
“comorbidity, particularly substance use disorders.(71,72) They also have”
Diagnosing ADHD in adolescence.
Sibley, M. H., Pelham, W. E., Molina, B. S. G., Gnagy, E. M., Waschbusch, D. A., Garefino, A. C., Kuriyan, A. B., Babinski, D. E., & Karch, K. M. (2012) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0026577 · Cited by 237 · cited 2×
“Despite these difficulties, clinicians need to try to obtain information from at least 2 teachers or other sources, such as coaches, school guidance counselors, or leaders of community activities in which the adolescent participates.(46) For the evaluation to be successful, it is essential that adolescents agree with…”
Parent–teen behavior therapy + motivational interviewing for adolescents with ADHD.
Sibley, M. H., Graziano, P. A., Kuriyan, A. B., Coxe, S., Pelham, W. E., Rodriguez, L., Sanchez, F., Derefinko, K., Helseth, S., & Ward, A. (2016) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000106 · Cited by 200 · cited 1×
“Overall, behavioral family approaches may be helpful to some adolescents and their families, and school-based training interventions are well established.(25,94) Meaningful improvements in functioning have not been reported from cognitive behavioral approaches.”
ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescents
Elia, J., Ambrosini, P., & Berrettini, W. (2008) · Child and Adolescent Psychiatry and Mental Health · doi:10.1186/1753-2000-2-15 · Cited by 196
Visser, S. N., Lesesne, C. A., & Perou, R. (2007) · Pediatrics · doi:10.1542/peds.2006-2089o · Cited by 196 · cited 1×
“As noted, ADHD is the most common neurobehavioral disorder of childhood, occurring in approximately 7% to 8% of children and youth.(8,18,28,29) Hence, the number of children with this condition is far greater than can be managed by the mental health system.”
Clonidine Extended-Release: In Attention-Deficit Hyperactivity Disorder
Croxtall, J. D. (2011) · Pediatric Drugs · doi:10.2165/11208100-000000000-00000 · Cited by 190
Cheng, J. Y. W., Chen, R. Y. L., Ko, J. S. N., & Ng, E. M. L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0840-x · Cited by 185 · cited 1×
“140 Authors of other reports suggest that more than 90% of patients will have a bene fi cial response to 1 of the psychostimulants if a range of medications from both the methylphenidate and amphetamine and/or dextroamphetamine classes”
Identifying students faking ADHD: Preliminary findings and strategies for detection
HARRISON, A., EDWARDS, M., & PARKER, K. (2007) · Archives of Clinical Neuropsychology · doi:10.1016/j.acn.2007.03.008 · Cited by 185 · cited 1×
“Certain substances, such as marijuana, can have effects that mimic ADHD; adolescent patients may also attempt to obtain stimulant medication to enhance performance (ie, academic, athletic, etc) by feigning symptoms.(48)”
Chan, E., Zhan, C., & Homer, C. J. (2002) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.156.5.504 · Cited by 183
Self-citationMcGoey, K. E., DuPaul, G. J., Haley, E., & Shelton, T. L. (2007) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-007-9048-y · Cited by 180
ADHD and Psychiatric Comorbidity: Functional Outcomes in a School-Based Sample of Children
Cuffe, S. P., Visser, S. N., Holbrook, J. R., Danielson, M. L., Geryk, L. L., Wolraich, M. L., & McKeown, R. E. (2020) · Journal of Attention Disorders · doi:10.1177/1087054715613437 · Cited by 175
Self-citationADHD Rating Scale-5 for Children and Adolescents: Checklists, Norms, and Clinical Interpretation
Zakeri, L. R. (2017) · School social work journal · Cited by 171
Dalsgaard, S., Leckman, J. F., Mortensen, P. B., Nielsen, H. S., & Simonsen, M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(15)00271-0 · Cited by 170 · cited 1×
“outcomes, such as motor vehicle crashes(78,79); criminality, including drug-related crimes(77) and violent reoffending(76); depression(71); interpersonal issues(80); and other injuries.(81,82)”
Chang, Z., Quinn, P. D., Hur, K., Gibbons, R. D., Sjölander, A., Larsson, H., & D’Onofrio, B. M. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0659 · Cited by 166 · cited 1×
“70 It is indicated in prospective studies that patients with ADHD, whether treated or not, are at increased risk for early death, suicide, and increased psychiatric The KASs are presented, followed by information on medication, psychosocial treatments, and special circumstances.”
Pringsheim, T., Hirsch, L., Gardner, D., & Gorman, D. A. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506000202 · Cited by 163 · cited 1×
“For example, treatment of ADHD may lead to improvement in coexisting aggression and/or oppositional defiant, depressive, or anxiety symptoms.(150,151)”
Barbaresi, W. J., Katusic, S. K., Colligan, R. C., Weaver, A. L., & Jacobsen, S. J. (2007) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0b013e3180cabc28 · Cited by 161
Hirota, T., Schwartz, S., & Correll, C. U. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.009 · Cited by 161 · cited 1×
“Only extended-release guanfacine and extended-release clonidine have evidence supporting their use as adjunctive therapy with stimulant medications sufficient to have achieved FDA approval.(127) Other medications have been used in combination on an off-label basis, with some limited evidence available to support the e…”
Cardiovascular Monitoring and Stimulant Drugs for Attention-Deficit/Hyperactivity Disorder
Perrin, J. M., Friedman, R. A., Knilans, T. K., the Black Box Working Group, & Surgery, T. S. O. C. A. C. (2008) · Pediatrics · doi:10.1542/peds.2008-1573 · Cited by 161
Scheffler, R. M., Brown, T. T., Fulton, B. D., Hinshaw, S. P., Levine, P., & Stone, S. (2009) · Pediatrics · doi:10.1542/peds.2008-1597 · Cited by 160
Cardiovascular Events and Death in Children Exposed and Unexposed to ADHD Agents
Schelleman, H., Bilker, W. B., Strom, B. L., Kimmel, S. E., Newcomb, C., Guevara, J. P., Daniel, G. W., Cziraky, M. J., & Hennessy, S. (2011) · Pediatrics · doi:10.1542/peds.2010-3371 · Cited by 159 · cited 1×
“In 114 – 118 Nevertheless, before initiating therapy with stimulant medications, it is important to obtain the child or adolescent ’ s history of speci fi c cardiac symptoms in addition to the family history of sudden death, cardiovascular symptoms, Wolff-Parkinson-White syndrome, hypertrophic…”
Mosholder, A. D., Gelperin, K., Hammad, T. A., Phelan, K., & Johann-Liang, R. (2009) · Pediatrics · doi:10.1542/peds.2008-0185 · Cited by 155
Evaluation of a school-based treatment program for young adolescents with ADHD.
Evans, S. W., Langberg, J. M., Schultz, B. K., Vaughn, A., Altaye, M., Marshall, S. A., & Zoromski, A. K. (2016) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000057 · Cited by 155
Self-citationChang, Z., D’Onofrio, B. M., Quinn, P. D., Lichtenstein, P., & Larsson, H. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.018 · Cited by 154 · cited 1×
“comorbidity, particularly substance use disorders.(71,72) They also have”
Meta-Analysis of Suicide-Related Behavior Events in Patients Treated With Atomoxetine
BANGS, M. E., TAUSCHER-WISNIEWSKI, S., POLZER, J., ZHANG, S., ACHARYA, N., DESAIAH, D., TRZEPACZ, P. T., & ALLEN, A. J. (2008) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e31815d88b2 · Cited by 152
The comorbidity of ADHD and autism spectrum disorder
Antshel, K. M., Zhang-James, Y., & Faraone, S. V. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.840417 · Cited by 147
Examining the Comorbidity of Language Impairment and Attention-Deficit/Hyperactivity Disorder
Mueller, K. L., & Tomblin, J. B. (2012) · Topics in Language Disorders · doi:10.1097/tld.0b013e318262010d · Cited by 144 · cited 15×
“5,6 To assist pediatricians and other PCCs in overcoming such obstacles, the companion article on systemic barriers to the care of children and adolescents with ADHD reviews the barriers and makes recommendations to address them to enhance care for children and adolescents with ADHD.”
InfluentialEducational Accommodations for Students With Behavioral Challenges
Harrison, J. R., Bunford, N., Evans, S. W., & Owens, J. S. (2013) · Review of Educational Research · doi:10.3102/0034654313497517 · Cited by 144 · cited 1×
“The second category is intended to provide changes in the student’s program so his or her ADHD-related problems no longer result in failure and cause distress to parents, teachers, and the student.(144) These services are referred to as “accommodations” and include extended time to complete tests and assignments, redu…”
Self-citationJain, R., Segal, S., Kollins, S. H., & Khayrallah, M. (2011) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.11.005 · Cited by 142 · cited 1×
“140 Authors of other reports suggest that more than 90% of patients will have a bene fi cial response to 1 of the psychostimulants if a range of medications from both the methylphenidate and amphetamine and/or dextroamphetamine classes”
Biederman, J., Faraone, S., Wozniak, J., Mick, E., Kwon, A., & Aleardi, M. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.05.021 · Cited by 142
(2016) · doi:10.1037/t05638-000 · Cited by 142
Child Health Disparities: What Can a Clinician Do?
Cheng, T. L., Emmanuel, M. A., Levy, D. J., & Jenkins, R. R. (2015) · PEDIATRICS · doi:10.1542/peds.2014-4126 · Cited by 139
Attention Deficit–Hyperactivity Disorder and Month of School Enrollment
Layton, T., Barnett, M. L., Hicks, T. R., & Jena, A. B. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1806828 · Cited by 139 · cited 1×
“Although there is a greater risk of receiving a diagnosis of ADHD for children who are the youngest in their class (who are therefore less developmentally capable of compensating for their weaknesses), for most children, retention is not beneficial.(22)”
Egger, H. L., Kondo, D., & Angold, A. (2006) · Infants & Young Children · doi:10.1097/00001163-200604000-00004 · Cited by 137 · cited 2×
“For extended-release guanfacine and extended-release clonidine, adverse effects include somnolence, dry mouth, dizziness, irritability, headache, bradycardia, hypotension, and abdominal pain.(30,124,125) Because rebound hypertension after abrupt guanfacine and clonidine discontinuation has been observed,(126) these me…”
The Prevalence of ADHD in a Population-Based Sample
Rowland, A. S., SKIPPER, B. J., Umbach, D. M., Rabiner, D. L., Campbell, R. A., Naftel, A. J., & Sandler, D. P. (2013) · Journal of Attention Disorders · doi:10.1177/1087054713513799 · Cited by 135 · cited 1×
“5%.(9,10) National survey data from 2016 indicate that 9.”
Attention-Deficit/Hyperactivity Disorder and Substance Abuse
Harstad, E., Levy, S., COMMITTEE ON SUBSTANCE ABUSE, Levy, S., Ammerman, S. D., Gonzalez, P. K., Ryan, S. A., Siqueira, L. M., & Smith, V. C. (2014) · Pediatrics · doi:10.1542/peds.2014-0992 · Cited by 131 · cited 2×
“70 It is indicated in prospective studies that patients with ADHD, whether treated or not, are at increased risk for early death, suicide, and increased psychiatric The KASs are presented, followed by information on medication, psychosocial treatments, and special circumstances.”
McGough, J. J., Sturm, A., Cowen, J., Tung, K., Salgari, G. C., Leuchter, A. F., Cook, I. A., Sugar, C. A., & Loo, S. K. (2019) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2018.11.013 · Cited by 131 · cited 1×
“Although it is FDA approved, the efficacy for external trigeminal nerve stimulation (eTNS) is documented by one 5-week randomized controlled trial with just 30 participants receiving eTNS.(90) To date, there is no long-term safety and efficacy evidence for eTNS.”
Jerome, L., Habinski, L., & Segal, A. (2006) · Current Psychiatry Reports · doi:10.1007/s11920-006-0045-8 · Cited by 130 · cited 1×
“Given the risks of driving for adolescents with ADHD, including crashes and motor vehicle violations, special concern should be taken to provide medication coverage for symptom control while driving.(79,136,137) Longer-acting or lateafternoon, short-acting medications may be helpful in this regard.”
Chang, Z., Lichtenstein, P., Långström, N., Larsson, H., & Fazel, S. (2016) · JAMA · doi:10.1001/jama.2016.15380 · Cited by 130 · cited 1×
“70 It is indicated in prospective studies that patients with ADHD, whether treated or not, are at increased risk for early death, suicide, and increased psychiatric The KASs are presented, followed by information on medication, psychosocial treatments, and special circumstances.”
A DSM-IV–Referenced Screening Instrument for Preschool Children: The Early Childhood Inventory-4
SPRAFKIN, J., VOLPE, R. J., GADOW, K. D., NOLAN, E. E., & KELLY, K. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200205000-00018 · Cited by 128
McCarthy, S., Cranswick, N., Potts, L., Taylor, E., & Wong, I. C. K. (2009) · Drug Safety · doi:10.2165/11317630-000000000-00000 · Cited by 128
Attention Deficit Hyperactivity Disorder in Preschool Children
Greenhill, L. L., Posner, K., Vaughan, B. S., & Kratochvil, C. J. (2008) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2007.11.004 · Cited by 126
Mahajan, R., Bernal, M. P., Panzer, R., Whitaker, A. H., Roberts, W., Handen, B. L., Hardan, A. Y., Anagnostou, E. A., & Veenstra-VanderWeele, J. M. (2012) · PEDIATRICS · doi:10.1542/peds.2012-0900j · Cited by 123
(2002) · PubMed · Cited by 119
Comparison of Attention-Deficit/Hyperactivity Disorder Symptom Subtypes in Ukrainian Schoolchildren
GADOW, K. D., NOLAN, E. E., LITCHER, L., CARLSON, G. A., PANINA, N., GOLOVAKHA, E., SPRAFKIN, J., & BROMET, E. J. (2000) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200012000-00014 · Cited by 114
Reed, V. A., Buitelaar, J. K., Anand, E., Day, K. A., Treuer, T., Upadhyaya, H. P., Coghill, D. R., Kryzhanovskaya, L. A., & Savill, N. C. (2016) · CNS Drugs · doi:10.1007/s40263-016-0349-0 · Cited by 113
Wolraich, M. L., McKeown, R. E., Visser, S. N., Bard, D., Cuffe, S. P., Neas, B. R., Geryk, L. L., Doffing, M., Bottai, M., Abramowitz, A. J., et al. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712453169 · Cited by 111
Self-citationSnoring, Sleep Quality, and Sleepiness Across Attention-Deficit/Hyperactivity Disorder Subtypes
(2004) · Sleep · doi:10.1093/sleep/27.3.520 · Cited by 109
Pastor, P. N., & Reuben, C. A. (2005) · Public Health Reports® · doi:10.1177/003335490512000405 · Cited by 109 · cited 1×
“Special attention should be given to these populations when assessing comorbidities as they relate to ADHD and when treating for ADHD symptoms.(3) Given the nationwide problem of limited access to mental health clinicians,(4) pediatricians and other PCCs are increasingly called on to provide services to patients with…”
Patterns of Comorbidity Among Girls With ADHD: A Meta-analysis
Tung, I., Li, J. J., Meza, J. I., Jezior, K. L., Kianmahd, J. S. V., Hentschel, P. G., O’Neil, P. M., & Lee, S. S. (2016) · Pediatrics · doi:10.1542/peds.2016-0430 · Cited by 108
Harvey, E. A., Youngwirth, S. D., Thakar, D. A., & Errazuriz, P. A. (2009) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0014638 · Cited by 102
Holbrook, J. R., Cuffe, S. P., Cai, B., Visser, S. N., Forthofer, M. S., Bottai, M., Ortaglia, A., & McKeown, R. E. (2016) · Journal of Attention Disorders · doi:10.1177/1087054714539997 · Cited by 99 · cited 1×
“As individuals with ADHD enter adolescence, their overt hyperactive and impulsive symptoms tend to decline, whereas their inattentive symptoms tend to persist.(13,14) Learning and language problems are common comorbid conditions with ADHD.”
Self-citationCox, D. J., Merkel, R. L., Moore, M., Thorndike, F., Muller, C., & Kovatchev, B. (2006) · PEDIATRICS · doi:10.1542/peds.2005-2947 · Cited by 95 · cited 1×
“Longer-acting or lateafternoon, short-acting medications may be helpful in this regard.(138)”
Progress and Promise of Attention-Deficit Hyperactivity Disorder Pharmacogenetics
Froehlich, T. E., McGough, J., & Stein, M. (2010) · CNS Drugs · doi:10.2165/11530290-000000000-00000 · Cited by 91
Self-citationDiagnostic Experiences of Children With Attention-Deficit/Hyperactivity Disorder.
Visser, S. N., Zablotsky, B., Holbrook, J. R., Danielson, M. L., & Bitsko, R. H. (2015) · PubMed · Cited by 91
Self-citationCOMMITTEE ON PEDIATRIC WORKFORCE, Pletcher, B. A., Rimsza, M. E., Basco, W. T., Hotaling, A. J., Sigrest, T. D., & Simon, F. A. (2013) · Pediatrics · doi:10.1542/peds.2013-2268 · Cited by 88
Crabtree, V. M., Ivanenko, A., & Gozal, D. (2003) · Clinical Pediatrics · doi:10.1177/000992280304200906 · Cited by 80
Spencer, T. J., Kratochvil, C. J., Sangal, R. B., Saylor, K. E., Bailey, C. E., Dunn, D. W., Geller, D. A., Casat, C. D., Lipetz, R. S., Jain, R., et al. (2007) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2006.0100 · Cited by 75 · cited 1×
“Decreases were observed among those who were taller or heavier than average before treatment.(123)”
Pastor, P. N., Reuben, C. A., Duran, C. R., & Hawkins, L. D. (2015) · PubMed · Cited by 74
Langberg, J. M., Dvorsky, M. R., Molitor, S. J., Bourchtein, E., Eddy, L. D., Smith, Z. R., Oddo, L. E., & Eadeh, H.-M. (2018) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000265 · Cited by 74
RIGGS, P. D., & Jellinek, M. S. (1998) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199803000-00019 · Cited by 73 · cited 1×
“Clinicians should also be aware that adolescents are at greater risk for substance use than are younger children.(44,45,47) Certain substances, such as marijuana, can have effects that mimic ADHD; adolescent patients may also attempt to obtain stimulant medication to enhance performance (ie, academic, athletic, etc) b…”
A Double-Blind, Placebo-Controlled Study of Atomoxetine in Young Children With ADHD
Kratochvil, C. J., Vaughan, B. S., Stoner, J. A., Daughton, J. M., Lubberstedt, B. D., Murray, D. W., Chrisman, A. K., Faircloth, M. A., Itchon-Ramos, N. B., Kollins, S. H., et al. (2011) · Pediatrics · doi:10.1542/peds.2010-0825 · Cited by 70 · cited 1×
“None.”
Hepatic Events Associated with Atomoxetine Treatment for??Attention-Deficit??Hyperactivity Disorder
Bangs, M. E., Jin, L., Zhang, S., Desaiah, D., Allen, A. J., Read, H. A., Regev, A., & Wernicke, J. F. (2008) · Drug Safety · doi:10.2165/00002018-200831040-00008 · Cited by 68 · cited 1×
“Risks, harm, cost Higher levels of medication increase the chances of side effects.”
Kambeitz, J., Romanos, M., & Ettinger, U. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2013.9 · Cited by 64
A Current Update on ADHD Pharmacogenomics
Kieling, C., Genro, J. P., Hutz, M. H., & Rohde, L. A. (2010) · Pharmacogenomics · doi:10.2217/pgs.10.28 · Cited by 62
Attention Deficit Hyperactivity Disorder: Diagnosis and Treatment in Children and Adolescents
Kemper, A. R., Maslow, G., Hill, S., Namdari, B., LaPointe, N. M. A., Goode, A. P., Coeytaux, R. R., Befus, D., Kosinski, A. S., Bowen, S., et al. (2017) · doi:10.23970/ahrqepccer203 · Cited by 59
Treuer, T., Gau, S. S.-F., Méndez, L., Montgomery, W., Monk, J. A., Altin, M., Wu, S., Lin, C. C. H., & Dueñas, H. J. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0093 · Cited by 58 · cited 15×
“5,6 To assist pediatricians and other PCCs in overcoming such obstacles, the companion article on systemic barriers to the care of children and adolescents with ADHD reviews the barriers and makes recommendations to address them to enhance care for children and adolescents with ADHD.”
InfluentialDifferential Reimbursement of Psychiatric Services by Psychiatrists and Other Medical Providers
Mark, T. L., Olesiuk, W. J., Ali, M. M., Sherman, L. J., Mutter, R. L., & Teich, J. L. (2017) · Psychiatric Services · doi:10.1176/appi.ps.201700271 · Cited by 53 · cited 1×
“Unfortunately, thirdparty payers seldom pay appropriately for these timeconsuming services.(5,6)”
Adolescent Outcome of ADHD: Impact of Childhood Conduct and Anxiety Disorders
Newcorn, J. H., Miller, S. R., Ivanova, I., Schulz, K. P., Kalmar, J. H., Marks, D. J., & Halperin, J. M. (2004) · CNS Spectrums · doi:10.1017/s1092852900001942 · Cited by 50
Screening for Poverty and Poverty-Related Social Determinants of Health
Berman, R. S., Patel, M. R., Belamarich, P. F., & Gross, R. S. (2018) · Pediatrics In Review · doi:10.1542/pir.2017-0123 · Cited by 49 · cited 2×
“It is also important for PCCs to be aware of health disparities and social determinants that may impact patient outcomes and strive to provide culturally appropriate care to all children and adolescents in their practice.(145,146,154,155)”
Middle School–based and High School–based Interventions for Adolescents with ADHD
Evans, S. W., Langberg, J. M., Egan, T., & Molitor, S. J. (2014) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2014.05.004 · Cited by 48 · cited 1×
“that they will benefit younger children, as well.(25,89) Some training”
Self-citationPredictors of Medication Continuity in Children With ADHD
Brinkman, W. B., Sucharew, H., Majcher, J. H., & Epstein, J. N. (2018) · Pediatrics · doi:10.1542/peds.2017-2580 · Cited by 47
Pharmacotherapy of Pediatric Attention-Deficit/Hyperactivity Disorder
Vaughan, B., & Kratochvil, C. J. (2012) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2012.07.005 · Cited by 46
ADHD pharmacogenetics across the life cycle: New findings and perspectives
Bruxel, E. M., Akutagava-Martins, G. C., Salatino-Oliveira, A., Contini, V., Kieling, C., Hutz, M., & Rohde, L. (2014) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32240 · Cited by 44
Fabiano, G. A., Schatz, N. K., Morris, K. L., Willoughby, M. T., Vujnovic, R. K., Hulme, K. F., Riordan, J., Howard, M., Hennessy, D., Lewis, K., et al. (2016) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000137 · Cited by 43
Medicare Advantage And Commercial Prices For Mental Health Services
Pelech, D., & Hayford, T. (2019) · Health Affairs · doi:10.1377/hlthaff.2018.05226 · Cited by 43 · cited 1×
“Unfortunately, thirdparty payers seldom pay appropriately for these timeconsuming services.(5,6)”
Trends in Abstaining From Substance Use in Adolescents: 1975–2014
Levy, S., Campbell, M. D., Shea, C. L., & DuPont, R. L. (2018) · PEDIATRICS · doi:10.1542/peds.2017-3498 · Cited by 42 · cited 1×
“The importance of adequately treating ADHD outweighs the risk of adverse effects.”
Raman, S. R., Marshall, S. W., Haynes, K., Gaynes, B. N., Naftel, A. J., & Stürmer, T. (2012) · Injury Prevention · doi:10.1136/injuryprev-2012-040483 · Cited by 41 · cited 1×
“outcomes, such as motor vehicle crashes(78,79); criminality, including drug-related crimes(77) and violent reoffending(76); depression(71); interpersonal issues(80); and other injuries.(81,82)”
The Phenomenology of Attention-Deficit/Hyperactivity Disorder in Tourette Syndrome
Rothenberger, A., & Roessner, V. (2013) · Oxford University Press eBooks · doi:10.1093/med/9780199796267.003.0002 · Cited by 39
Outcomes for adolescents who comply with long-term psychosocial treatment for ADHD.
Schultz, B. K., Evans, S. W., Langberg, J. M., & Schoemann, A. M. (2017) · Journal of Consulting and Clinical Psychology · doi:10.1037/ccp0000172 · Cited by 37 · cited 1×
“It is helpful for clinicians to be aware of the eligibility criteria in their states and school districts to advise families of their options.”
Self-citationCommon Comorbidities Seen in Adolescents With Attention-Deficit/Hyperactivity Disorder
Young, J. (2008) · AM:STARs: ADHD/Learning Disorders, Vol. 19, No. 2 · doi:10.1542/9781581104035-common · Cited by 36 · cited 1×
“None.”
Approaching ADHD as a Chronic Condition: Implications for Long-Term Adherence
Van Cleave, J., & Leslie, L. K. (2008) · Journal of Psychosocial Nursing and Mental Health Services · doi:10.3928/02793695-20080801-07 · Cited by 35
The ADD Hyperactivity Handbook For Schools
Parker, H. C. (2014) · Routledge eBooks · doi:10.4324/9781315798639 · Cited by 30
Preventive Intervention for Early Childhood Behavioral Problems: An Ecological Perspective
Shepard, S. A., & Dickstein, S. (2009) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2009.03.002 · Cited by 29 · cited 1×
“established treatments with preadolescent children.(25,87,88) Most”
Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review
Froehlich, T. E., Fogler, J., Barbaresi, W. J., Elsayed, N. A., Evans, S. W., & Chan, E. (2018) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1192 · Cited by 28
Self-citationParent reported preschool attention deficit hyperactivity: measurement and validity
Pavuluri, M. N., Luk, S.-L., & McGee, R. (1999) · European Child & Adolescent Psychiatry · doi:10.1007/s007870050093 · Cited by 24
Scope of Health Care Benefits for Children From Birth Through Age 26
COMMITTEE ON CHILD HEALTH FINANCING, Long, T. F., Chiu, T., Helm, M. E., Libby, R. C., Racine, A. D., Shenkin, B. N., Snider, I. G., White, P. H., Berkelhamer, J. E., et al. (2012) · Pediatrics · doi:10.1542/peds.2011-2936 · Cited by 22
Brown, J. T., & Bishop, J. R. (2015) · Pharmacogenomics · doi:10.2217/pgs.15.93 · Cited by 19
Interpreting the Prevalence of Mental Disorders in Children
Holbrook, J. R., Bitsko, R. H., Danielson, M. L., & Visser, S. N. (2016) · Health Promotion Practice · doi:10.1177/1524839916677730 · Cited by 16 · cited 1×
“Prevalence estimates of ADHD vary on the basis of differences in research methodologies, the various age groups being described, and changes in diagnostic criteria over time.(7) Authors of a recent meta-analysis calculated a pooled worldwide ADHD prevalence of 7.”
Self-citationThe Enhanced Medical Home: The Pediatric Standard of Care for Medically Underserved Children
Brito, A., Grant, R., Overholt, S., Aysola, J., Pino, I., Spalding, S. H., Prinz, T., & Redlener, I. (2008) · Advances in Pediatrics · doi:10.1016/j.yapd.2008.07.007 · Cited by 15 · cited 2×
“In addition, the medical home model has been accepted as the preferred standard of care for children with chronic conditions.(69)”
Joensen, B., Meyer, M., & Aagaard, L. (2017) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_16_161 · Cited by 14 · cited 1×
“140 Authors of other reports suggest that more than 90% of patients will have a bene fi cial response to 1 of the psychostimulants if a range of medications from both the methylphenidate and amphetamine and/or dextroamphetamine classes”
Poblano, A., & Romero, E. (2006) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2006000600008 · Cited by 13
Focus on Guanfacine Extended-release: A Review of its Use in Child and Adolescent Psychiatry.
(2014) · Europe PMC (PubMed Central) · Cited by 12
Mental Health Care of Children and Adolescents: A Guide for Primary Care Clinicians
(2018) · American Academy of Pediatrics eBooks · doi:10.1542/9781610021517 · Cited by 10
New Resources and Strategies to Advance the AAP’s Values of Diversity, Inclusion, and Health Equity
Stein, F., Remley, K., Laraque‐Arena, D., et al. (2018) · PEDIATRICS · doi:10.1542/peds.2018-0177 · Cited by 7 · cited 1×
“It is also important for PCCs to be aware of health disparities and social determinants that may impact patient outcomes and strive to provide culturally appropriate care to all children and adolescents in their practice.(145,146,154,155)”
Algorithm: A Process for Integrating Mental Health Care Into Pediatric Practice
(2018) · American Academy of Pediatrics eBooks · doi:10.1542/9781610021517-appendix_1 · Cited by 1 · cited 2×
“The recommendations made in this guideline are intended to be integrated with the broader mental health algorithm developed as part of the AAP Mental Health Initiatives.”
Research works printed but not linked: 5
- American Academy of Pediatrics Task Force on Mental Health, 2010, Addressing Mental Health Concerns in Primary Care: A Clinician’s Toolkit [CD-ROM]
- Wolraich, 1996, The Classification of Child and Adolescent Mental Conditions in Primary Care: Diagnostic and Statistical Manual for Primary Care (DSM-PC), Child and Adolescent Version
- Robin, 1989, The Guilford Family Therapy Series. Negotiating Parent–Adolescent Conflict: A Behavioral–Family Systems Approach
- Avigan, 2004, Review of AERS Data From Marketed Safety Experience During Stimulant Therapy: Death, Sudden Death, Cardiovascular SAEs (Including Stroke). Report No. D030403
- Davila, 1991, Memorandum on clarification of policy to address the needs of children with attention deficit disorders within general and/or special education, 261
Cited by
Sorted by citations
Mental Health Surveillance Among Children — United States, 2013–2019
Bitsko, R. H., Claussen, A. H., Lichstein, J., Black, L. I., Jones, S. E., Danielson, M. L., Hoenig, J. M., Davis Jack, S. P., Brody, D. J., Gyawali, S., et al. (2022) · MMWR Supplements · doi:10.15585/mmwr.su7102a1 · Cited by 1,723
Hampl, S. E., Hassink, S. G., Skinner, A. C., Armstrong, S. C., Barlow, S. E., Bolling, C. F., Avila Edwards, K. C., Eneli, I., Hamre, R., Joseph, M. M., et al. (2023) · Pediatrics · doi:10.1542/peds.2022-060640 · Cited by 1,389
Self-citationLipkin, P. H., Macias, M. M., COUNCIL ON CHILDREN WITH DISABILITIES, S. O. D. A. B. P., Norwood, K. W., Brei, T. J., Davidson, L. F., Davis, B. E., Ellerbeck, K. A., Houtrow, A. J., Hyman, S. L., et al. (2020) · Pediatrics · doi:10.1542/peds.2019-3449 · Cited by 676
Hinshaw, S. P., Nguyen, P. T., O’Grady, S. M., & Rosenthal, E. A. (2022) · Journal of Child Psychology and Psychiatry · doi:10.1111/jcpp.13480 · Cited by 424
“Despite evidence-based guidelines prepared by the American Academy of Child and Ado-lescent Psychiatry (Pliszka & AACAP Work Group on Quality Issues, 2007) and the American Academy of Pediatrics (Wolraich et al., 2019) in the United States, and the National Institute for Health and Care Excellence (2019) in the U.K.,…”
BackgroundMethodYeung, A., Ng, E., & Abi-Jaoude, E. (2022) · The Canadian Journal of Psychiatry · doi:10.1177/07067437221082854 · Cited by 355
Metadata
- Authors
- Wolraich, M. L., Hagan, J. F., Allan, C., Chan, E., Davison, D., Earls, M., Evans, S. W., Flinn, S. K., Froehlich, T., Frost, J., Holbrook, J. R., Lehmann, C. U., Lessin, H. R., Okechukwu, K., Pierce, K. L., Winner, J. D., Zurhellen, W., & DISORDER, S. O. C. A. A. W. A.-D.
- Affiliations
- University of Oklahoma (US)
- University of Vermont (US)
- Children's Mercy Hospital (US)
- Boston Children's Hospital (US)
- Children and Adults with Attention Deficit/Hyperactivity Disorder (US)
- University of North Carolina at Chapel Hill (US)
- Ohio University (US)
- American Academy of Pediatrics (US)
- Cincinnati Children's Hospital Medical Center (US)
- American Academy of Family Physicians (US)
- Centers for Disease Control and Prevention (US)
- Vanderbilt University (US)
- uThe Children’s Medical Group, Poughkeepsie, New York;
- Northwestern University (US)
- yAtlanta, Georgia; and
- zHolderness, New Hampshire
- Corresponding author
- Wolraich, Mark L.
- ORCID
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2019-10-01
- Volume
- 144
- Issue
- 4
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- PMC
- PMC7067282
- OpenAlex
- W4213383170
- Semantic Scholar
- b0fa6ec69e8a7d09cc706e5e07fce062628ce632
- Cited by
- 1,562
- References
- 152
- Citations by year
- 2026: 309 · 2025: 288 · 2024: 257 · 2023: 218 · 2022: 202 · 2021: 173 · 2020: 102 · 2019: 8
- FWCI
- 88.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- Funders
- National Institutes of Health (CC999999)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Keywords
- attention deficit hyperactivity disorder, ADHD treatment, comorbidities, children and adolescents, DSM-5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review